What is Zacks Research’s Forecast for CME Group Q2 Earnings?

CME Group Inc. (NASDAQ:CMEFree Report) – Investment analysts at Zacks Research lifted their Q2 2025 earnings per share (EPS) estimates for shares of CME Group in a note issued to investors on Monday, May 12th. Zacks Research analyst T. De now expects that the financial services provider will post earnings of $2.85 per share for the quarter, up from their previous forecast of $2.61. The consensus estimate for CME Group’s current full-year earnings is $10.49 per share. Zacks Research also issued estimates for CME Group’s Q3 2025 earnings at $2.74 EPS, Q4 2025 earnings at $2.59 EPS, FY2025 earnings at $10.98 EPS, Q1 2026 earnings at $2.78 EPS, Q2 2026 earnings at $2.91 EPS, Q3 2026 earnings at $2.62 EPS, Q4 2026 earnings at $2.95 EPS, FY2026 earnings at $11.26 EPS, Q1 2027 earnings at $2.93 EPS and FY2027 earnings at $12.06 EPS.

CME Group (NASDAQ:CMEGet Free Report) last issued its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, topping analysts’ consensus estimates of $2.61 by $0.19. The firm had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The company’s revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.50 earnings per share.

Several other equities research analysts have also commented on CME. UBS Group lifted their price target on shares of CME Group from $290.00 to $305.00 and gave the stock a “buy” rating in a research note on Friday, April 25th. Barclays lifted their target price on CME Group from $279.00 to $283.00 and gave the stock an “equal weight” rating in a research report on Wednesday, April 23rd. Piper Sandler raised their price target on CME Group from $275.00 to $283.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 8th. Keefe, Bruyette & Woods boosted their price objective on CME Group from $265.00 to $273.00 and gave the company a “market perform” rating in a research note on Thursday, April 24th. Finally, Bank of America raised their target price on shares of CME Group from $200.00 to $219.00 and gave the stock an “underperform” rating in a research report on Wednesday, April 2nd. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $256.80.

Read Our Latest Analysis on CME

CME Group Stock Up 2.9%

CME stock opened at $274.00 on Thursday. The stock has a market cap of $98.74 billion, a P/E ratio of 28.34, a PEG ratio of 6.76 and a beta of 0.45. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group has a twelve month low of $190.70 and a twelve month high of $286.48. The company’s 50 day moving average is $265.54 and its two-hundred day moving average is $246.70.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Wayfinding Financial LLC acquired a new stake in CME Group in the 1st quarter worth about $25,000. Cornerstone Planning Group LLC boosted its position in shares of CME Group by 122.2% in the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 55 shares during the last quarter. SJS Investment Consulting Inc. grew its holdings in CME Group by 570.6% in the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 97 shares during the period. Golden State Wealth Management LLC grew its holdings in CME Group by 612.5% in the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 98 shares during the period. Finally, Alpine Bank Wealth Management acquired a new position in CME Group during the first quarter worth approximately $32,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insiders Place Their Bets

In other news, COO Suzanne Sprague sold 1,500 shares of CME Group stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $256.83, for a total transaction of $385,245.00. Following the completion of the sale, the chief operating officer now directly owns 8,036 shares in the company, valued at $2,063,885.88. The trade was a 15.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Derek Sammann sold 4,650 shares of the company’s stock in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the transaction, the insider now directly owns 8,336 shares in the company, valued at $2,339,164.96. The trade was a 35.81% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 23,134 shares of company stock valued at $6,087,434. Corporate insiders own 0.30% of the company’s stock.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be issued a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.82%. The ex-dividend date is Monday, June 9th. CME Group’s dividend payout ratio (DPR) is presently 50.30%.

About CME Group

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.